Results
1 -
10 of
37Laninamivir/paracetamol/zanamivir, Reactions Weekly Antiviral Drugs for the Treatment and Prevention of Influenza, Current Treatment Options in Infectious Diseases Antiviral Resistance in Influenza Viruses: Clinical and Epidemiological Aspects, Antimicrobial Drug Resistance Japanese Surveillance Systems and Treatment for Influenza, Current Treatment Options in Infectious Diseases Clinical Pharmacokinetics of Inhaled Antimicrobials, Clinical Pharmacokinetics The Bright Side of Bird Flu, Pharmaceutical & Diagnostic Innovation Thermal Conductivity of Hydride Powders Layers Interacted With Hydrogen, Carbon Nanomaterials in Clean Energy Hydrogen Systems Impact of the number of repeated inhalations and patient characteristics on the residual amount of inhaled laninamivir octanoate hydrate dry powder in pediatric patients with influenza, Journal of Pharmaceutical Health Care and Sciences Clinical efficacy of long-acting neuraminidase inhibitor laninamivir octanoate hydrate in postmarketing surveillance, Journal of Infection and Chemotherapy High and continuous exposure of laninamivir, an anti-influenza drug, may work suppressively to generate low-susceptibility mutants in animals, Journal of Infection and Chemotherapy